nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—HTR2C—metabolic syndrome X	0.784	1	CbGaD
Maprotiline—SLC6A2—sympathetic nervous system—metabolic syndrome X	0.0103	0.117	CbGeAlD
Maprotiline—HTR7—sympathetic nervous system—metabolic syndrome X	0.00996	0.112	CbGeAlD
Maprotiline—HTR2A—arteriole—metabolic syndrome X	0.00975	0.11	CbGeAlD
Maprotiline—SLC6A2—autonomic nervous system—metabolic syndrome X	0.00695	0.0784	CbGeAlD
Maprotiline—HTR7—autonomic nervous system—metabolic syndrome X	0.0067	0.0756	CbGeAlD
Maprotiline—HTR2A—sympathetic nervous system—metabolic syndrome X	0.00621	0.0701	CbGeAlD
Maprotiline—HTR2A—autonomic nervous system—metabolic syndrome X	0.00418	0.0471	CbGeAlD
Maprotiline—HTR7—artery—metabolic syndrome X	0.0038	0.0429	CbGeAlD
Maprotiline—HTR7—endothelium—metabolic syndrome X	0.00321	0.0362	CbGeAlD
Maprotiline—HTR7—blood vessel—metabolic syndrome X	0.00296	0.0334	CbGeAlD
Maprotiline—HTR2A—artery—metabolic syndrome X	0.00237	0.0267	CbGeAlD
Maprotiline—HTR2A—endothelium—metabolic syndrome X	0.002	0.0226	CbGeAlD
Maprotiline—HTR2A—blood vessel—metabolic syndrome X	0.00185	0.0208	CbGeAlD
Maprotiline—CHRM2—cardiovascular system—metabolic syndrome X	0.0017	0.0192	CbGeAlD
Maprotiline—CHRM1—cardiovascular system—metabolic syndrome X	0.00155	0.0175	CbGeAlD
Maprotiline—CHRM3—kidney—metabolic syndrome X	0.00136	0.0153	CbGeAlD
Maprotiline—HTR7—cardiovascular system—metabolic syndrome X	0.00132	0.0149	CbGeAlD
Maprotiline—Metixene—HTR2C—metabolic syndrome X	0.0013	0.322	CrCbGaD
Maprotiline—HTR7—kidney—metabolic syndrome X	0.00129	0.0146	CbGeAlD
Maprotiline—CHRM3—adipose tissue—metabolic syndrome X	0.00122	0.0138	CbGeAlD
Maprotiline—ABCB1—blood vessel—metabolic syndrome X	0.00121	0.0136	CbGeAlD
Maprotiline—Nasal congestion—Metformin—metabolic syndrome X	0.00121	0.0392	CcSEcCtD
Maprotiline—ORM1—liver—metabolic syndrome X	0.00113	0.0127	CbGeAlD
Maprotiline—Liver function test abnormal—Metformin—metabolic syndrome X	0.00101	0.033	CcSEcCtD
Maprotiline—Breast disorder—Metformin—metabolic syndrome X	0.000993	0.0323	CcSEcCtD
Maprotiline—Sweating increased—Metformin—metabolic syndrome X	0.000925	0.0301	CcSEcCtD
Maprotiline—HRH1—adipose tissue—metabolic syndrome X	0.000869	0.00981	CbGeAlD
Maprotiline—Drowsiness—Metformin—metabolic syndrome X	0.000847	0.0275	CcSEcCtD
Maprotiline—Infestation—Metformin—metabolic syndrome X	0.000847	0.0275	CcSEcCtD
Maprotiline—Infestation NOS—Metformin—metabolic syndrome X	0.000847	0.0275	CcSEcCtD
Maprotiline—Neuropathy peripheral—Metformin—metabolic syndrome X	0.00083	0.027	CcSEcCtD
Maprotiline—HTR2A—cardiovascular system—metabolic syndrome X	0.000823	0.00929	CbGeAlD
Maprotiline—HTR7—liver—metabolic syndrome X	0.000816	0.00921	CbGeAlD
Maprotiline—HTR2A—kidney—metabolic syndrome X	0.000805	0.00909	CbGeAlD
Maprotiline—Hepatobiliary disease—Metformin—metabolic syndrome X	0.000801	0.0261	CcSEcCtD
Maprotiline—Atomoxetine—HTR2C—metabolic syndrome X	0.000762	0.189	CrCbGaD
Maprotiline—Hepatitis—Metformin—metabolic syndrome X	0.00076	0.0247	CcSEcCtD
Maprotiline—Hypoaesthesia—Metformin—metabolic syndrome X	0.000757	0.0246	CcSEcCtD
Maprotiline—CYP2D6—kidney—metabolic syndrome X	0.000734	0.00828	CbGeAlD
Maprotiline—Eye disorder—Metformin—metabolic syndrome X	0.000711	0.0231	CcSEcCtD
Maprotiline—Flushing—Metformin—metabolic syndrome X	0.000706	0.023	CcSEcCtD
Maprotiline—Cardiac disorder—Metformin—metabolic syndrome X	0.000706	0.023	CcSEcCtD
Maprotiline—Angiopathy—Metformin—metabolic syndrome X	0.00069	0.0224	CcSEcCtD
Maprotiline—Mediastinal disorder—Metformin—metabolic syndrome X	0.000685	0.0223	CcSEcCtD
Maprotiline—Nortriptyline—HTR2C—metabolic syndrome X	0.000665	0.165	CrCbGaD
Maprotiline—Malnutrition—Metformin—metabolic syndrome X	0.000662	0.0215	CcSEcCtD
Maprotiline—CYP1A2—liver—metabolic syndrome X	0.000651	0.00735	CbGeAlD
Maprotiline—Dysgeusia—Metformin—metabolic syndrome X	0.000648	0.0211	CcSEcCtD
Maprotiline—Vision blurred—Metformin—metabolic syndrome X	0.000624	0.0203	CcSEcCtD
Maprotiline—Tremor—Metformin—metabolic syndrome X	0.00062	0.0202	CcSEcCtD
Maprotiline—Syncope—Metformin—metabolic syndrome X	0.000594	0.0193	CcSEcCtD
Maprotiline—Palpitations—Metformin—metabolic syndrome X	0.000585	0.019	CcSEcCtD
Maprotiline—Loss of consciousness—Metformin—metabolic syndrome X	0.000582	0.0189	CcSEcCtD
Maprotiline—Hypertension—Metformin—metabolic syndrome X	0.000571	0.0186	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.00056	0.0182	CcSEcCtD
Maprotiline—Desipramine—HTR2C—metabolic syndrome X	0.000548	0.136	CrCbGaD
Maprotiline—Oedema—Metformin—metabolic syndrome X	0.00054	0.0176	CcSEcCtD
Maprotiline—ABCB1—cardiovascular system—metabolic syndrome X	0.000539	0.00609	CbGeAlD
Maprotiline—Infection—Metformin—metabolic syndrome X	0.000537	0.0175	CcSEcCtD
Maprotiline—Shock—Metformin—metabolic syndrome X	0.000531	0.0173	CcSEcCtD
Maprotiline—Nervous system disorder—Metformin—metabolic syndrome X	0.00053	0.0172	CcSEcCtD
Maprotiline—Thrombocytopenia—Metformin—metabolic syndrome X	0.000529	0.0172	CcSEcCtD
Maprotiline—ABCB1—kidney—metabolic syndrome X	0.000528	0.00596	CbGeAlD
Maprotiline—Skin disorder—Metformin—metabolic syndrome X	0.000525	0.0171	CcSEcCtD
Maprotiline—Hyperhidrosis—Metformin—metabolic syndrome X	0.000522	0.017	CcSEcCtD
Maprotiline—HTR2A—liver—metabolic syndrome X	0.000509	0.00575	CbGeAlD
Maprotiline—Hypotension—Metformin—metabolic syndrome X	0.000505	0.0164	CcSEcCtD
Maprotiline—Paraesthesia—Metformin—metabolic syndrome X	0.000485	0.0158	CcSEcCtD
Maprotiline—Somnolence—Metformin—metabolic syndrome X	0.00048	0.0156	CcSEcCtD
Maprotiline—ABCB1—adipose tissue—metabolic syndrome X	0.000476	0.00537	CbGeAlD
Maprotiline—Dyspepsia—Metformin—metabolic syndrome X	0.000476	0.0155	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000466	0.0152	CcSEcCtD
Maprotiline—Fatigue—Metformin—metabolic syndrome X	0.000466	0.0151	CcSEcCtD
Maprotiline—Imipramine—HTR2C—metabolic syndrome X	0.000465	0.115	CrCbGaD
Maprotiline—CYP2D6—liver—metabolic syndrome X	0.000464	0.00523	CbGeAlD
Maprotiline—Constipation—Metformin—metabolic syndrome X	0.000462	0.015	CcSEcCtD
Maprotiline—Feeling abnormal—Metformin—metabolic syndrome X	0.000445	0.0145	CcSEcCtD
Maprotiline—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000442	0.0144	CcSEcCtD
Maprotiline—Urticaria—Metformin—metabolic syndrome X	0.000429	0.014	CcSEcCtD
Maprotiline—Abdominal pain—Metformin—metabolic syndrome X	0.000427	0.0139	CcSEcCtD
Maprotiline—Asthenia—Metformin—metabolic syndrome X	0.000388	0.0126	CcSEcCtD
Maprotiline—Pruritus—Metformin—metabolic syndrome X	0.000382	0.0124	CcSEcCtD
Maprotiline—Diarrhoea—Metformin—metabolic syndrome X	0.00037	0.012	CcSEcCtD
Maprotiline—Dizziness—Metformin—metabolic syndrome X	0.000357	0.0116	CcSEcCtD
Maprotiline—Vomiting—Metformin—metabolic syndrome X	0.000343	0.0112	CcSEcCtD
Maprotiline—Rash—Metformin—metabolic syndrome X	0.000341	0.0111	CcSEcCtD
Maprotiline—Dermatitis—Metformin—metabolic syndrome X	0.00034	0.0111	CcSEcCtD
Maprotiline—Headache—Metformin—metabolic syndrome X	0.000338	0.011	CcSEcCtD
Maprotiline—ABCB1—liver—metabolic syndrome X	0.000334	0.00376	CbGeAlD
Maprotiline—Nausea—Metformin—metabolic syndrome X	0.000321	0.0104	CcSEcCtD
Maprotiline—Nortriptyline—ALB—metabolic syndrome X	0.00029	0.072	CrCbGaD
Maprotiline—CHRM1—Signaling Pathways—IGF2—metabolic syndrome X	1.69e-05	0.000182	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IGF2—metabolic syndrome X	1.68e-05	0.000181	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—APOB—metabolic syndrome X	1.67e-05	0.00018	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IGF2—metabolic syndrome X	1.67e-05	0.000179	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IRS1—metabolic syndrome X	1.66e-05	0.000179	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—INS—metabolic syndrome X	1.66e-05	0.000179	CbGpPWpGaD
Maprotiline—ABCB1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	1.66e-05	0.000179	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—PPARA—metabolic syndrome X	1.65e-05	0.000177	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—APOB—metabolic syndrome X	1.65e-05	0.000177	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—APOB—metabolic syndrome X	1.64e-05	0.000177	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—SREBF1—metabolic syndrome X	1.64e-05	0.000176	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—APOB—metabolic syndrome X	1.64e-05	0.000176	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CCL5—metabolic syndrome X	1.63e-05	0.000176	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CCL2—metabolic syndrome X	1.63e-05	0.000176	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—APOB—metabolic syndrome X	1.63e-05	0.000176	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.63e-05	0.000175	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—APOB—metabolic syndrome X	1.62e-05	0.000174	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—SERPINE1—metabolic syndrome X	1.62e-05	0.000174	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CCL5—metabolic syndrome X	1.61e-05	0.000173	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IGF1—metabolic syndrome X	1.61e-05	0.000173	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CCL5—metabolic syndrome X	1.6e-05	0.000173	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.6e-05	0.000173	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CCL5—metabolic syndrome X	1.6e-05	0.000172	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.6e-05	0.000172	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—LPL—metabolic syndrome X	1.6e-05	0.000172	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—AGT—metabolic syndrome X	1.59e-05	0.000172	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CCL5—metabolic syndrome X	1.59e-05	0.000172	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—HMGCR—metabolic syndrome X	1.59e-05	0.000172	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GOT2—metabolic syndrome X	1.59e-05	0.000172	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.59e-05	0.000172	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—INS—metabolic syndrome X	1.59e-05	0.000171	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.59e-05	0.000171	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CCL5—metabolic syndrome X	1.58e-05	0.00017	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.57e-05	0.000169	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—LPL—metabolic syndrome X	1.57e-05	0.000169	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—LPL—metabolic syndrome X	1.57e-05	0.000169	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CCL2—metabolic syndrome X	1.56e-05	0.000169	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—LPL—metabolic syndrome X	1.56e-05	0.000168	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—APOE—metabolic syndrome X	1.56e-05	0.000168	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—LPL—metabolic syndrome X	1.56e-05	0.000168	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—NAMPT—metabolic syndrome X	1.56e-05	0.000168	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—AGT—metabolic syndrome X	1.55e-05	0.000167	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	1.55e-05	0.000167	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—LIPC—metabolic syndrome X	1.55e-05	0.000167	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GCK—metabolic syndrome X	1.55e-05	0.000167	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—APOA1—metabolic syndrome X	1.54e-05	0.000166	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—LPL—metabolic syndrome X	1.54e-05	0.000166	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—NOS3—metabolic syndrome X	1.54e-05	0.000166	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IGF1—metabolic syndrome X	1.54e-05	0.000166	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—APOC3—metabolic syndrome X	1.54e-05	0.000166	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—SERPINE1—metabolic syndrome X	1.53e-05	0.000164	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—APOE—metabolic syndrome X	1.52e-05	0.000163	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—LEP—metabolic syndrome X	1.52e-05	0.000163	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—ABCA1—metabolic syndrome X	1.51e-05	0.000162	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—SLC2A4—metabolic syndrome X	1.51e-05	0.000162	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—APOA1—metabolic syndrome X	1.5e-05	0.000162	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CETP—metabolic syndrome X	1.49e-05	0.000161	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—SERPINE1—metabolic syndrome X	1.46e-05	0.000157	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—GOT1—metabolic syndrome X	1.46e-05	0.000157	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—GGT1—metabolic syndrome X	1.46e-05	0.000157	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—NOS3—metabolic syndrome X	1.46e-05	0.000157	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—SCARB1—metabolic syndrome X	1.43e-05	0.000154	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—ABCA1—metabolic syndrome X	1.42e-05	0.000153	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—SLC2A4—metabolic syndrome X	1.42e-05	0.000153	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—NOS3—metabolic syndrome X	1.39e-05	0.00015	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	1.39e-05	0.00015	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—SREBF1—metabolic syndrome X	1.39e-05	0.00015	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GGT1—metabolic syndrome X	1.38e-05	0.000148	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GOT1—metabolic syndrome X	1.38e-05	0.000148	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—AGT—metabolic syndrome X	1.37e-05	0.000147	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—PPARG—metabolic syndrome X	1.36e-05	0.000147	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IRS1—metabolic syndrome X	1.35e-05	0.000146	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GOT2—metabolic syndrome X	1.35e-05	0.000145	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—HMGCR—metabolic syndrome X	1.35e-05	0.000145	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—AGT—metabolic syndrome X	1.35e-05	0.000145	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—AGT—metabolic syndrome X	1.34e-05	0.000145	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—LEP—metabolic syndrome X	1.34e-05	0.000144	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—APOE—metabolic syndrome X	1.34e-05	0.000144	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—AGT—metabolic syndrome X	1.34e-05	0.000144	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—INS—metabolic syndrome X	1.33e-05	0.000144	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—AGT—metabolic syndrome X	1.33e-05	0.000144	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—APOA1—metabolic syndrome X	1.32e-05	0.000143	CbGpPWpGaD
Maprotiline—HTR7—GPCR downstream signaling—AKT1—metabolic syndrome X	1.32e-05	0.000142	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—AGT—metabolic syndrome X	1.32e-05	0.000142	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—LEP—metabolic syndrome X	1.32e-05	0.000142	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—APOE—metabolic syndrome X	1.32e-05	0.000142	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—LEP—metabolic syndrome X	1.32e-05	0.000142	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—APOE—metabolic syndrome X	1.32e-05	0.000142	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—APOE—metabolic syndrome X	1.31e-05	0.000141	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—LEP—metabolic syndrome X	1.31e-05	0.000141	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—LEP—metabolic syndrome X	1.31e-05	0.000141	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—APOE—metabolic syndrome X	1.31e-05	0.000141	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—APOA1—metabolic syndrome X	1.3e-05	0.00014	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—IL6—metabolic syndrome X	1.3e-05	0.00014	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—APOA1—metabolic syndrome X	1.3e-05	0.00014	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—INS—metabolic syndrome X	1.3e-05	0.00014	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—APOA1—metabolic syndrome X	1.3e-05	0.00014	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—APOE—metabolic syndrome X	1.29e-05	0.000139	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—LEP—metabolic syndrome X	1.29e-05	0.000139	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—APOA1—metabolic syndrome X	1.29e-05	0.000139	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—APOA1—metabolic syndrome X	1.28e-05	0.000138	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CCL2—metabolic syndrome X	1.28e-05	0.000137	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IGF1—metabolic syndrome X	1.25e-05	0.000135	CbGpPWpGaD
Maprotiline—CHRM4—GPCR downstream signaling—AKT1—metabolic syndrome X	1.25e-05	0.000134	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—APOB—metabolic syndrome X	1.24e-05	0.000133	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—IL6—metabolic syndrome X	1.23e-05	0.000132	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—ALB—metabolic syndrome X	1.22e-05	0.000132	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	1.22e-05	0.000131	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	1.21e-05	0.00013	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—ABCA1—metabolic syndrome X	1.2e-05	0.00013	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—SLC2A4—metabolic syndrome X	1.2e-05	0.00013	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—AKT1—metabolic syndrome X	1.2e-05	0.000129	CbGpPWpGaD
Maprotiline—CHRM5—GPCR downstream signaling—AKT1—metabolic syndrome X	1.2e-05	0.000129	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IRS1—metabolic syndrome X	1.19e-05	0.000129	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—SERPINE1—metabolic syndrome X	1.19e-05	0.000128	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—LPL—metabolic syndrome X	1.18e-05	0.000127	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—IL6—metabolic syndrome X	1.18e-05	0.000127	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IRS1—metabolic syndrome X	1.18e-05	0.000127	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IRS1—metabolic syndrome X	1.17e-05	0.000126	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—NOS3—metabolic syndrome X	1.17e-05	0.000126	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IRS1—metabolic syndrome X	1.17e-05	0.000126	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—APOB—metabolic syndrome X	1.17e-05	0.000126	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IRS1—metabolic syndrome X	1.17e-05	0.000126	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GOT1—metabolic syndrome X	1.17e-05	0.000126	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GGT1—metabolic syndrome X	1.17e-05	0.000126	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IRS1—metabolic syndrome X	1.15e-05	0.000124	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—INS—metabolic syndrome X	1.14e-05	0.000123	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—NOS3—metabolic syndrome X	1.14e-05	0.000122	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	1.14e-05	0.000122	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—AKT1—metabolic syndrome X	1.13e-05	0.000122	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—INS—metabolic syndrome X	1.13e-05	0.000121	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CCL2—metabolic syndrome X	1.13e-05	0.000121	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—CD36—metabolic syndrome X	1.12e-05	0.000121	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—INS—metabolic syndrome X	1.12e-05	0.000121	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—INS—metabolic syndrome X	1.12e-05	0.000121	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—INS—metabolic syndrome X	1.12e-05	0.00012	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—LPL—metabolic syndrome X	1.11e-05	0.00012	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CCL2—metabolic syndrome X	1.11e-05	0.000119	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IGF1—metabolic syndrome X	1.11e-05	0.000119	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—INS—metabolic syndrome X	1.11e-05	0.000119	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CCL2—metabolic syndrome X	1.11e-05	0.000119	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CCL2—metabolic syndrome X	1.1e-05	0.000119	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CCL2—metabolic syndrome X	1.1e-05	0.000118	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IGF1—metabolic syndrome X	1.09e-05	0.000117	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CCL2—metabolic syndrome X	1.09e-05	0.000117	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IGF1—metabolic syndrome X	1.09e-05	0.000117	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—AKT1—metabolic syndrome X	1.09e-05	0.000117	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IGF1—metabolic syndrome X	1.08e-05	0.000117	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IGF1—metabolic syndrome X	1.08e-05	0.000116	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—PTGS2—metabolic syndrome X	1.07e-05	0.000115	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IGF1—metabolic syndrome X	1.07e-05	0.000115	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—CD36—metabolic syndrome X	1.06e-05	0.000114	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—SERPINE1—metabolic syndrome X	1.05e-05	0.000113	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PPARA—metabolic syndrome X	1.04e-05	0.000113	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—SERPINE1—metabolic syndrome X	1.03e-05	0.000111	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—SERPINE1—metabolic syndrome X	1.03e-05	0.000111	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—SERPINE1—metabolic syndrome X	1.03e-05	0.000111	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—SERPINE1—metabolic syndrome X	1.03e-05	0.00011	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—TGFB1—metabolic syndrome X	1.02e-05	0.00011	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—SERPINE1—metabolic syndrome X	1.02e-05	0.000109	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—AGT—metabolic syndrome X	1.01e-05	0.000109	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—NOS3—metabolic syndrome X	1e-05	0.000108	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—APOE—metabolic syndrome X	9.92e-06	0.000107	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—APOB—metabolic syndrome X	9.89e-06	0.000107	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—NOS3—metabolic syndrome X	9.87e-06	0.000106	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—NOS3—metabolic syndrome X	9.85e-06	0.000106	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PPARA—metabolic syndrome X	9.85e-06	0.000106	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—NOS3—metabolic syndrome X	9.82e-06	0.000106	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—APOA1—metabolic syndrome X	9.8e-06	0.000106	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—NOS3—metabolic syndrome X	9.79e-06	0.000105	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—AKT1—metabolic syndrome X	9.74e-06	0.000105	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—NOS3—metabolic syndrome X	9.69e-06	0.000104	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—TGFB1—metabolic syndrome X	9.63e-06	0.000104	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PLA2G4A—metabolic syndrome X	9.62e-06	0.000104	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—IL6—metabolic syndrome X	9.59e-06	0.000103	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—AGT—metabolic syndrome X	9.54e-06	0.000103	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—LPL—metabolic syndrome X	9.44e-06	0.000102	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—APOE—metabolic syndrome X	9.34e-06	0.000101	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—APOA1—metabolic syndrome X	9.24e-06	9.95e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—TGFB1—metabolic syndrome X	9.22e-06	9.93e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CD36—metabolic syndrome X	8.97e-06	9.66e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—AKT1—metabolic syndrome X	8.85e-06	9.53e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PPARG—metabolic syndrome X	8.64e-06	9.3e-05	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—AKT1—metabolic syndrome X	8.6e-06	9.26e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—INS—metabolic syndrome X	8.47e-06	9.12e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—IL6—metabolic syndrome X	8.46e-06	9.12e-05	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—AKT1—metabolic syndrome X	8.46e-06	9.11e-05	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—AKT1—metabolic syndrome X	8.44e-06	9.09e-05	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—AKT1—metabolic syndrome X	8.41e-06	9.06e-05	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—AKT1—metabolic syndrome X	8.39e-06	9.04e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PPARA—metabolic syndrome X	8.34e-06	8.98e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—IL6—metabolic syndrome X	8.33e-06	8.97e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—IL6—metabolic syndrome X	8.31e-06	8.95e-05	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—AKT1—metabolic syndrome X	8.31e-06	8.95e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—IL6—metabolic syndrome X	8.28e-06	8.92e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—IL6—metabolic syndrome X	8.26e-06	8.89e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—IL6—metabolic syndrome X	8.18e-06	8.81e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PPARG—metabolic syndrome X	8.14e-06	8.77e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—AGT—metabolic syndrome X	8.08e-06	8.7e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—INS—metabolic syndrome X	7.98e-06	8.6e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—APOE—metabolic syndrome X	7.92e-06	8.53e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—APOA1—metabolic syndrome X	7.82e-06	8.43e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—AKT1—metabolic syndrome X	7.81e-06	8.41e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—ALB—metabolic syndrome X	7.77e-06	8.36e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—IL6—metabolic syndrome X	7.68e-06	8.28e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—AKT1—metabolic syndrome X	7.68e-06	8.28e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—AKT1—metabolic syndrome X	7.67e-06	8.26e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—AKT1—metabolic syndrome X	7.64e-06	8.23e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—AKT1—metabolic syndrome X	7.62e-06	8.21e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—AKT1—metabolic syndrome X	7.54e-06	8.13e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TGFB1—metabolic syndrome X	7.52e-06	8.1e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—NOS3—metabolic syndrome X	7.43e-06	8e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—ALB—metabolic syndrome X	7.32e-06	7.88e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IL6—metabolic syndrome X	7.26e-06	7.82e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—AKT1—metabolic syndrome X	7.09e-06	7.64e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—NOS3—metabolic syndrome X	7e-06	7.54e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IL6—metabolic syndrome X	6.95e-06	7.49e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PPARG—metabolic syndrome X	6.89e-06	7.43e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PTGS2—metabolic syndrome X	6.79e-06	7.32e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—INS—metabolic syndrome X	6.76e-06	7.28e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—AKT1—metabolic syndrome X	6.69e-06	7.21e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TGFB1—metabolic syndrome X	6.63e-06	7.15e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TGFB1—metabolic syndrome X	6.53e-06	7.03e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TGFB1—metabolic syndrome X	6.51e-06	7.02e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TGFB1—metabolic syndrome X	6.49e-06	6.99e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TGFB1—metabolic syndrome X	6.47e-06	6.97e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—AKT1—metabolic syndrome X	6.41e-06	6.91e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TGFB1—metabolic syndrome X	6.41e-06	6.9e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	6.4e-06	6.9e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—ALB—metabolic syndrome X	6.2e-06	6.68e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—NOS3—metabolic syndrome X	5.93e-06	6.39e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IL6—metabolic syndrome X	5.67e-06	6.1e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PTGS2—metabolic syndrome X	5.42e-06	5.84e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—AKT1—metabolic syndrome X	5.38e-06	5.8e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—AKT1—metabolic syndrome X	5.23e-06	5.63e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IL6—metabolic syndrome X	5e-06	5.39e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IL6—metabolic syndrome X	4.92e-06	5.3e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IL6—metabolic syndrome X	4.91e-06	5.29e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IL6—metabolic syndrome X	4.89e-06	5.27e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IL6—metabolic syndrome X	4.88e-06	5.25e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IL6—metabolic syndrome X	4.83e-06	5.2e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—AKT1—metabolic syndrome X	4.61e-06	4.97e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—AKT1—metabolic syndrome X	4.54e-06	4.89e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—AKT1—metabolic syndrome X	4.53e-06	4.88e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—AKT1—metabolic syndrome X	4.51e-06	4.86e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—AKT1—metabolic syndrome X	4.5e-06	4.85e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—AKT1—metabolic syndrome X	4.46e-06	4.8e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—AKT1—metabolic syndrome X	3.41e-06	3.68e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—AKT1—metabolic syndrome X	3.22e-06	3.47e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—AKT1—metabolic syndrome X	2.73e-06	2.94e-05	CbGpPWpGaD
